CJC-1295 no-DAC and CJC-1295 with DAC share a familiar catalog name while referring to different seller-labelled research formats. This comparison keeps their separate 5 mg price boards, availability states, evidence-access labels, and source pages visible so a shorthand search does not collapse two identities into one product row.
The no-DAC board is categorized as a modified growth hormone-releasing factor analogue research material, while the DAC board is categorized as a drug-affinity-complex growth hormone-releasing factor analogue research material. The naming distinction must remain attached to every price and document claim.
Modified growth hormone-releasing factor analogue research material
Drug-affinity-complex growth hormone-releasing factor analogue research material
Price ranges use rows marked in stock. “Public evidence route” means a seller exposed a document link; it does not establish authenticity, chain of custody, purity, sterility, or vial contents.
| Comparison field | CJC-1295 no DAC | CJC-1295 DAC |
|---|---|---|
| Editorial family | Growth-signaling analogues | Growth-signaling analogues |
| Seller-listed identity | Modified growth hormone-releasing factor analogue research material | Drug-affinity-complex growth hormone-releasing factor analogue research material |
| Nominal board size | 5 mg | 5 mg |
| Available list range | $46.00–$74.79 | $46.00–$52.00 |
| Median available price | $60.40 | $49.00 |
| Lowest available / mg | $9.20 | $9.20 |
| Available rows | 2 of 3 | 2 of 3 |
| Public evidence routes | 2 rows | 3 rows |
| Evidence only on request | 1 rows | 0 rows |
| Available-price spread | 63% | 13% |
| Snapshot checked | Jul 23, 2026 | Jul 23, 2026 |
Per-milligram figures normalize the seller’s nominal quantity only. They are not a cross-compound value, potency, effect, or dose comparison.
This is the site’s clearest same-name collision: seller pages may shorten either format to CJC-1295, making exact label, nominal size, and source URL essential before prices are compared.
Confirm whether a seller page explicitly says DAC or no-DAC before using its price.
Do not transfer a certificate, availability label, or price between the two catalog formats.
The comparison describes public research listings and does not supply dosing, duration, or therapeutic guidance.
These official context records explain why Peptide Local keeps research listings outside medical and approved-product lanes. They do not certify any seller or material.
FDA lists CJC-1295 among bulk substances that may present significant safety risks in compounding and describes limited clinical safety information. This board is specifically for seller-labelled 5 mg no-DAC or Modified GRF (1-29) research material.
Read the FDA source ↗FDA lists CJC-1295 among bulk substances that may present significant safety risks in compounding and describes limited clinical safety information. The DAC and no-DAC forms are kept on separate boards because their seller-labelled identities differ.
Read the FDA source ↗